Yi Wang

Yi Wang


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2017 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
YCYong Chen
Yong Chen
LZLi Zhao
Li Zhao
YWYi Wang
Yi Wang
MCMing Cao
Ming Cao
VGViolet Gelowani
Violet Gelowani
Rui ChenRui Chen
Rui Chen
Targeted next-generation sequencing (NGS) has been widely used as a cost-effective way to identify the genetic basis of human disorders. Copy number variations (CNVs) contribute significantly to human genomic variability, some of which can lead to disease. However, effective detection of CNVs from targeted capture sequencing data remains challenging. Here we present SeqCNV, a novel CNV calling method designed to use capture NGS data. SeqCNV extracts the read depth information and utilizes the maximum penalized likelihood estimation (MPLE) model to identify the copy number ratio and CNV boundary. We applied SeqCNV to both bacterial artificial clone (BAC) and human patient NGS data to identify CNVs. These CNVs were validated by array comparative genomic hybridization (aCGH). SeqCNV is able to robustly identify CNVs of different size using capture NGS data. Compared with other CNV-calling methods, SeqCNV shows a significant improvement in both sensitivity and specificity.

25 July 2018 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
KWKun Wang
Kun Wang
MZMenghan Zhang
Menghan Zhang
YLYi Li
Yi Li
WPWeilin Pu
Weilin Pu
YMYanyun Ma
Yanyun Ma
LJLi Jin
Li Jin
High-altitude headache (HAH) is the most common sickness occurred in healthy people after rapid ascending to high altitude, and its risk factors were still not well understood. To investigate physiological, hematological and biochemical risk factors associated with high-altitude headache (HAH) after acute exposure to 3700 m, we conducted a two-stage, perspective observational study. In 72 h, total 318 young Han Chinese males ascended from sea level (altitude of 50 m) to altitude of 3700 m by train. Demographic data, physiological, hematological and biochemical parameters of all participants were collected within one week prior to the departure, and within 24 h after arrival. The incidence of HAH was 74.84%. For parameters measured at sea level, participants with HAH exhibited significantly higher age and lower BUN (p < 0.05). For parameters measured at 3700 m, participants with HAH exhibited significantly lower blood oxygen saturation (SpO2), higher resting heart rate (HR), higher systolic blood pressure at resting (SBP) and lower blood urea nitrogen (BUN) (all p < 0.05). At 3700 m, the severity of HAH associated with SpO2, HR and BUN significantly (all p < 0.05). Multivariate logistic regression revealed that for parameters at sea level, BUN was associated with HAH [BUN (OR:0.77, 95% CI:0.60–0.99)] and for parameters at 3700 m, SpO2, HR and BUN were associated with HAH independently [SpO2 (OR:0.84, 95% CI:0.76–0.93); HR (OR:1.03, 95% CI:1.00–1.07); BUN (OR:0.64, 95% CI:0.46–0.88)]. No association between hematological parameters and HAH was observed. We confirmed that higher HR, lower SpO2 are independent risk factors for HAH. Furthermore, we found that at both 50 m and 3700 m, lower BUN is a novel independent risk factor for HAH, providing new insights for understanding the pathological mechanisms.

1 January 2021 in Journal of Investigative Medicine
Verified
Journal Article
Open access
PDF file
YLYi Li
Yi Li
MLMeng Liang
Meng Liang
XYXianhong Yin
Xianhong Yin
XLXiaoyu Liu
Xiaoyu Liu
MHMeng Hao
Meng Hao
LJLi Jin
Li Jin
COVID-19 raised tension both within China and internationally. Here, we used mathematical modeling to predict the trend of patient diagnosis outside China in future, with the aim of easing anxiety regarding the emergent situation. According to all diagnosis number from WHO website and combining with the transmission mode of infectious diseases, the mathematical model was fitted to predict future trend of outbreak. Daily diagnosis numbers from countries outside China were downloaded from WHO situation reports. The data used for this analysis were collected from January 21, 2020 and currently end at February 28, 2020. A simple regression model was developed based on these numbers, as follows: , where is the total diagnosed patient till the i-th day and t=1 at February 1, 2020. Based on this model, we estimate that there were approximately 34 undetected founder patients at the beginning of the spread of COVID-19 outside China. The global trend was approximately exponential, with an increase rate of 10-fold every 19 days. Through establishment of this model, we call for worldwide strong public health actions, with reference to the experiences learned from China and Singapore.


23 December 2016 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
SLSong Liu
Song Liu
YWYi Wang
Yi Wang
FWFei Wang
Fei Wang
The next-generation of sequencing technologies, along with the development of bioinformatics, are generating a growing number of reads every day. For the convenience of further research, these reads should be aligned to the reference genome by read alignment tools. Despite the diversity of read alignment tools, most have no comprehensive advantage in both accuracy and speed. For example, BWA has comparatively high accuracy, but its speed leaves much to be desired, becoming a bottleneck while an increasing number of reads need to be aligned every day. We believe that the speed of read alignment tools still has huge room for improvement, while maintaining little to no loss in accuracy. Here we implement a new read alignment tool, Fast Seed-and-Vote Aligner (FSVA), which is based on seeding and voting. FSVA achieves a high accuracy close to BWA and simultaneously has a very high speed. It only requires ~10–15 CPU hours to run a whole genome read alignment, which is ~5–7 times faster than BWA. In some cases, reads have to be aligned in a short time. Where requirement of accuracy is not very stringent, FSVA would be a promising option. FSVA is available at https://github.com/Topwood91/FSVA

3 March 2020 in medRxiv
Verified
Preprint
Open access
PDF file
YLYi Li
Yi Li
MLMeng Liang
Meng Liang
XYXianhong Yin
Xianhong Yin
XLXiaoyu Liu
Xiaoyu Liu
MHMeng Hao
Meng Hao
LJLi Jin
Li Jin
Summary: Background: In December 2019, pneumonia infected with a novel coronavirus burst in Wuhan, China. Now the situation is almost controlled in China but is worse outside China. We aimed to build a mathematical model to capture the global trend of epidemics outside China. Methods: In this retrospective, outside-China diagnosis number reported from Jan 21 to Feb 28, 2020 was downloaded from WHO website. We develop a simple regression model on these numbers: where N t is the total diagnosed patient till the i th day, t=1 at Feb 1. Findings: Based on this model, we estimate that there have been about 34 unobserved founder patients at the beginning of spread outside China. The global trend is approximately exponential, with the rate of 10 folds every 19 days. Research in context: Evidence before this study: In December 2019, pneumonia infected with a novel coronavirus burst in Wuhan, China. Now the situation is almost controlled in China but is worse outside China. Now there are 4,691 patients across 51 countries and territories outside China. We searched PubMed and the China National Knowledge Infrastructure database for articles published up to Feb 28, 2020, using the keywords “COVID”, “novel coronavirus”, “2019-nCoV” or “2019 novel coronavirus”. No published work about the global trend of epidemics outside China could be identified. Added value of this study: We built a simple “log-plus” linear model to capture the global trend of epidemics outside China. We estimate that there have been about 34 unobserved founder patients at the beginning of spread outside China. The global trend is approximately exponential, with the rate of 10 folds every 19 days. Implications of all the available evidence: With the limited number of data points and the complexity of the real situation, a straightforward model is expected to work better. Our model suggests that the COVID-19 disease follows an approximate exponential growth model stably at the very beginning. We predict that the number of confirmed patients outside China will increase ten folds in every 19 days without strong intervention by applying our model. Powerful actions on public health should be taken to combat this epidemic all over the world.